Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits

Pharmaceutical Research

Volumn 15, Issue 12, 1998, Pages 1888-1894

  Ferron, Geraldine M ^a,b   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b WYETH AYERST RESEARCH   (United States)

Author keywords

Immunosuppressant; Interaction; Pharmac odynamics; Pharmacokinetics; Prednisolone; Rabbit; Sirolimus

Indexed keywords

PREDNISOLONE; RAPAMYCIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL DIVISION; CORTICOSTERONE; CROSS-OVER STUDIES; DRUG INTERACTIONS; FEMALE; GRANULOCYTES; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; PREDNISOLONE; RABBITS; SIROLIMUS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032425198     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011966308791     Document Type: Article

References (29)

1. R. E. Morris. Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant. Rev. 6:39-87 (1992).
2. S. M. Metclafe and F. M. Richards. Cyclosporine, FK506, and rapamycin: some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation 49:798-803 (1990).
3. D. T. Boumpas, F. Paliogianni, E. D. Anastassiou, and J. E. Balow. Glucocorticoid action on the immune system: molecular and cellular aspects. Clin. Exp. Rheumatol. 9:413-423 (1991).
4. G. M. Ferron and W. J. Jusko. Species and gender-related differences incyclosporine/prednisolone/sirolimus interaction in whole blood lymphocyte proliferation assays. J. Pharmacol. Exp. Ther. 286:191-200 (1998).
5. K. H. Lew, E. A. Ludwig, M. A. Milad, K. Donovan, E. Middleton, J. J. Ferry, and W. J. Jusko. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther 54:402-414 (1993).
6. W. J. Jusko, G. M. Ferron, S. M. Mis, B. D. Kahan, and J. J. Zimmerman. Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants. J. Clin. Pharmacol. 36:1100-1106 (1996).
7. M. Sattler, P. Guengerich, C.-H. Yun, U. Christians, and K.-F. Sewing. Cytochrome P450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab. Dispos. 20:753-761 (1992).
8. F. J. Frey and B. M. Frey. Urinary 6β-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. J. Lab. Clin. Med. 101:593-604 (1983).
9. I. A. Shah, P. H. Whiting, G. Omar, A. W. Thomson, and M. D. Burke. Effects of FK506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. Transplant. Proc. 23:2783-2785 (1991).
10. M. L. Rocci, N. F. Johnson, and W. J. Jusko. Serum protein binding of prednisolone in four species. J. Pharm. Sci. 69:977-978 (1980).
11. W. Piekoszewski, F. S. Chow, and W. J. Jusko. Disposition of tacrolimus (FK506) in rabbits: role of red blood cell binding in hepatic clearance. Drug Metab. Dispos. 21:690-698 (1993).
12. G. M. Ferron and W. J. Jusko. Species differences in sirolimus stability in humans, rabbits and rats. Drug Metab. Dispos. 26:83-84 (1998).
13. J. A. Wald and W. J. Jusko. Prednisolone pharmacodynamics: leukocyte trafficking in the rat. Life Sci. 55:371-378 (1994).
14. W. Piekoszewski, F. S. Chow, and W. J. Jusko. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. J. Pharmacol. Exp. Ther. 269:103-109 (1994).
15. W. J. Jusko, N. A. Pyszczynski, M. S. Bushway, R. D'Ambrosio, and S. M. Mis. Fifteen years of operation of high-performance liquid chromatograpic assay for prednisolone, cortisol and prednisone in plasma. J. Chromatogr. B. 658:47-54 (1994).
16. G. M. Ferron, W. D. Conway, and W. J. Jusko. Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standards: application to sirolimus (rapamycin) determination. J. Chromatogr. B. 703:243-251 (1997).
17. B. Drewinko, T. L. Loo, B. Brown, J. A. Gottlieb, and E. J. Freireich. Combination chemotherapy in vitro with adriamycin. Observation of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. Can. Biochem. Biophys. 1:187-195 (1976).
18. W. R. Greco, H. S. Park, and Y. M. Rustum. Application of a new approach for the quantitation of drug synergism to the combination of cisdiamminedichloroplatinium and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 50:5318-5327 (1990).
19. L. E. Gerlowski and R. K. Jain. Physiologically based pharmacokinetic modeling: principles and applications. J. Pharm. Sci. 72:1103-1127 (1983).
20. B. C. Frey, W. F. J. Frey, and A. L. de Weck. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J. Immunol. 133:2479-2487 (1984).
21. R. Yatscoff, D. LeGatt, R. Keenan, and P. Chackowsky. Blood distribution of rapamycin. Transplantation 56:1202-1206 (1993).
22. J. E. Kay, E. Sampore-Kwaters, F. Geraghty, and G. Y. Morgan. Uptake of FK506 by lymphocytes and erythrocytes. Transplant. Proc. 23:2760 (1991).
23. F. S. Chow, W. Piekoszewski, and W. J. Jusko. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab. Dispos. 25:610-616 (1997).
24. R. W. Yatscoff, P. Wang, K. Chan, D. Hicks, and J. Zimmerman. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations. Ther. Drug Monit. 17:666-671 (1995).
25. M. A. Milad, E. A. Ludwig, S. Anne, E. Middleton, and W. J. Jusko. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte traficking. J. Pharmacokinet. Biopharm. 22:469-480 (1994).
26. Y. M. Ning and E. R. Sanchez. Immunophilins, heat shock proteins, and glucocorticoid receptor actions in vivo. Methods 9:188-200 (1996).
27. A. S. Shoker. Immunopharmacologic therapy in renal transplantation. Pharmacotherapy 16:562-575 (1996).
28. D. E. Hricik, W. Y. Almawi, and T. B. Strom. Trends in the use of glucocorticoids in renal transplantation. Transplantation 57:979-989 (1994).
29. M. G. Murgia, S. Jordan, and B. D. Kahan. The side effect profile of sirolimus: a phase I study in quiescent cyclosporin-prednisone treated renal transplant patients. Kidney Int. 49:209-216 (1996).